Understanding FAM210B's role in HCC could reveal critical insights into the disease's molecular mechanisms and lead to the identification of novel therapeutic targets and biomarkers for personalized treatment approaches. The gene discussed is MIMS2; the disease is hepatocellular carcinoma.